Dr. Yessica R. Sachdeva

Internal Medicine
Institute For Liver Health LLC
2201 W Fairview St Ste 9, 
Chandler, AZ 
Accepting New Patients
Offers Telehealth
18 Years of Experience
Institute For Liver Health LLC
2201 W Fairview St Ste 9, 
Chandler, AZ 

Overview

Yessica Sachdeva is a primary care provider, practicing in Internal Medicine in Chandler, Arizona. She has been practicing medicine for over 18 years.

Her clinical expertise encompasses COVID-19, Nonalcoholic Steatohepatitis (NASH), Hepatitis, and Visceromegaly.

She is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 3 clinical trials. Dr. Sachdeva is currently accepting new patients.

Graduate Year

2008

Specialties

Internal Medicine

Licenses

Hospitalist in AZ

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MercyCare
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Institute for Liver Health LLC
2201 W Fairview St Ste 9, Chandler, AZ 85224
Other Locations
Office
2152 S Vineyard Ste 123, Mesa, AZ 85210

Additional Areas of Focus

Dr. Sachdeva has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
An Open-label, Non-comparator, Multicenter Study to Describe the Pharmacokinetics (PK), Pharmacodynamics (PD; Viral Load) and Safety Following a Single Intravenous or Intramuscular Dose of Sotrovimab in Pediatric Participants With Mild to Moderate COVID-19 at High Risk of Disease Progression
An Open-label, Non-comparator, Multicenter Study to Describe the Pharmacokinetics (PK), Pharmacodynamics (PD; Viral Load) and Safety Following a Single Intravenous or Intramuscular Dose of Sotrovimab in Pediatric Participants With Mild to Moderate COVID-19 at High Risk of Disease Progression
Enrollment Status: Terminated
Publish Date: January 03, 2024
Intervention Type: Biological
Study Drug: Sotrovimab
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
View 2 Less Clinical Trials

3 Total Publications

Pharmacokinetics and Safety of Single-Dose Sotrovimab in High-Risk Children and Adolescents With Mild-to-Moderate COVID-19.
Pharmacokinetics and Safety of Single-Dose Sotrovimab in High-Risk Children and Adolescents With Mild-to-Moderate COVID-19.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: March 27, 2025
Similar Doctors
Expertise in
9
conditions
Dr. Robert G. Nelson
Internal Medicine
Expertise in
9
conditions
Dr. Robert G. Nelson
Internal Medicine

Office

1550 E Indian School Rd, 
Phoenix, AZ 
 (15.4 miles away)
602-200-5201
Languages Spoken:
English

Robert Nelson is a primary care provider, practicing in Internal Medicine in Phoenix, Arizona. Dr. Nelson is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Diabetic Nephropathy, Type 2 Diabetes (T2D), Chronic Kidney Disease, Wilson Disease, and Sleeve Gastrectomy.

Expertise in
45
conditions
Dr. Mark S. Walmer
Internal Medicine
Expertise in
45
conditions
Dr. Mark S. Walmer
Internal Medicine
Before you request

East Valley Internal Medicine

2081 W Frye Rd, Ste 200, 
Chandler, AZ 
 (1.8 miles away)
480-821-3821
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Our mission is to provide the highest quality medical care in a supportive and comprehensive enviroment. We focus on each patient as an individual, taking the time to effect the best out comes. Dr. Walmer is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol. Dr. Walmer is board certified in American Board Of Internal Medicine and Internal Medicine. Dr. Walmer is currently accepting new patients.

Expertise in
155
conditions
Dr. Cheryl A. Maurice
Internal Medicine
Expertise in
155
conditions
Dr. Cheryl A. Maurice
Internal Medicine
Before you request

Ocotillo Internal Medicine Associates

3503 S Mercy Rd, 
Gilbert, AZ 
 (7.8 miles away)
480-895-5870
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Cheryl Maurice is a primary care provider, practicing in Internal Medicine in Gilbert, Arizona. Dr. Maurice is highly rated in 155 conditions, according to our data. Her clinical expertise encompasses High Cholesterol, Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Maurice is board certified in American Board Of Internal Medicine. Dr. Maurice is currently accepting new patients.

Frequently Asked Questions about Dr. Yessica R. Sachdeva

How do I make an appointment with Dr. Yessica R. Sachdeva?

You can book an appointment with Dr. Yessica R. Sachdeva by calling their office at 480-470-4000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Yessica R. Sachdeva a top-rated expert for COVID-19?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Yessica R. Sachdeva is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Yessica R. Sachdeva specialize in?

While Dr. Yessica R. Sachdeva is a Internal Medicine, they have specific expertise in COVID-19, Nonalcoholic Steatohepatitis (NASH), and Hepatitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Yessica R. Sachdeva participate in research or clinical trials?

Yes. Dr. Yessica R. Sachdeva has published 3 articles and abstracts on conditions like COVID-19. You can view a list of Dr. Yessica R. Sachdeva's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Yessica R. Sachdeva accept my insurance?

Dr. Yessica R. Sachdeva accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 480-470-4000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sachdeva's expertise for a condition
ConditionClose
        View All 19 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile